CRISPR Therapeutics AG【CRSP】 経常(税引前)利益の推移

機能の使い方
(単位:千ドル) 経常(税引前)利益 前年比(%)
1Q25 -134,887 +16.4%
3Q24 -85,066 -23.9%
2Q24 -125,121 +62.9%
1Q24 -115,867 +123.9%
3Q23 -111,740 -36.2%
2Q23 -76,817 -57.3%
1Q23 -51,745 -70.5%
3Q22 -175,124 +37.1%
2Q22 -179,716 -123.5%
1Q22 -175,609 +56.0%
3Q21 -127,748 +38.5%
2Q21 763,368 -1062.9%
1Q21 -112,588 +62.3%
3Q20 -92,239 -166.5%
2Q20 -79,277 +47.9%
1Q20 -69,354 +43.5%
3Q19 138,697 -374.2%
2Q19 -53,614 +40.0%
1Q19 -48,323 +71.3%
3Q18 -50,574 +110.7%
2Q18 -38,284 +74.2%
1Q18 -28,214 +33.1%
3Q17 -24,000 +63.4%
2Q17 -21,972 -
1Q17 -21,196 -
3Q16 -14,686 -